Testing effectiveness (Phase 2)Study completedNCT01406977
What this trial is testing
Dose Escalation Study to Evaluate the Safety and Tolerability of Multiple Infusions of BPS804 in Adults With Hypophosphatasia (HPP)
Who this might be right for
Hypophosphatasia
Ultragenyx Pharmaceutical Inc 8